Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

Dec 08, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that Aetna has agreed to cover its ThyraMir microRNA classifier test for thyroid nodules.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Featured Webinar

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Sponsored by
LGC SeraCare Life Sciences

This webinar features a panel of industry stakeholders in cancer diagnostics, proficiency testing and clinical care who will discuss the promise and challenges of liquid biopsy technologies in disease diagnosis, monitoring, and patient care management.

What's Popular?

In Cancer

  1. CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

  2. Chinese Team Applies WGS Liquid Biopsy Platform to Bladder Cancer Detection, Recurrence

    Premium

  3. Cyted Acquires Digital Pathology, Clinical Lab Services Provider Pathognomics

  4. Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.